2022

• Consequences of the Hsp110DE9 mutation in tumorigenesis and the 5-fluorouracil-based chemotherapy response in Msh2-deficient mice. Noel et al. Cell Mol Life Sci. 2022 Jun.
• Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. André et al. J Clin Oncol. 2022 Aug.
• Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142. André et al. Ann Oncol. 2022 Jun.

2021

• Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair. Ratovomanana et al. Gastroenterology. 2021 Sep.
• Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer. Cohen et al. J Immunother Cancer. 2021 Feb.
• Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials. Cohen et al. J Clin Oncol. 2021 Feb.
• Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. Colle et al. Eur J Cancer. 2021 Feb.

2020

• KEYNOTE-177 Investigators. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. André et al. N Engl J Med. 2020 Dec.
• Overcoming the challenges associated with universal screening for Lynch syndrome in colorectal and endometrial cancer. Benusiglio et al. Genet Med. 2020 Aug.
• Mechanisms and therapeutic implications of hypermutation in gliomas. Touat et al. Nature. 2020 Apr.
• Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. Pagès et al. Ann Oncol. 2020 Jul.
• Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164. Le et al. J Clin Oncol. 2020 Jan.
• RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study. Cohen et al. J Immunother Cancer. 2020 Nov.

2019

• Low temperature isothermal amplification of microsatellites drastically reduces stutter artifact formation and improves microsatellite instability detection in cancer. Daunay et al. Nucleic Acids Res. 2019 Dec.
• Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Bouvet et al. Gastroenterology. 2019 Aug.
• Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer-Beyond the Misdiagnosis-In Reply. Cohen et al. JAMA Oncol. 2019 May.
• Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies. Taieb et al. Ann Oncol. 2019 Sep.
• Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status. Cohen et al. JAMA Oncol. 2019 Apr.
• MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors. Svrcek et al. Bull Cancer. 2019 Feb.
• Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status. Cohen et al. JAMA Oncol. 2019 Jan.

2018

• Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability. Bokhari et al. Oncogenesis. 2018 Sep.
• Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability. Jonchere et al. Cell Mol Gastroenterol Hepatol. 2018 Jun.
• Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Lupinacci et al. Gastroenterology. 2018 Mar.
• Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. Overman et al. J Clin Oncol. 2018 Mar.
• The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors. Marisa et al. JNCI 2018 Jan.

2021